Farmacoriflessioni
La pratica medica basata sulle prove di efficacia
FEDERICO MARCHETTI
Divisione di Pediatria e Neonatologia, Ospedale Civile di Matera
Giugno 2000 - pagg. 382 -386
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Sackett DL, Rosenberg WMC, Gray, JAM,
et al. Evidence based medicine; what it is and
what it isn’t. BMJ 1996;312:71-2.
2. Liberati A (ed). La medicina delle prove di efficacia. Roma: Il Pensiero Scientifico Editore, 1997.
3. Mastroiacovo P, Bonati M (eds). Evidencebased medicine: Prospettive in Pediatria 1998; 111:147-221.
4. Haynes B, Haines A. Barriers and bridges to evidence based clinical practice. BMJ 1998;317:273-6.
5. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998;317:465-8.
6. Cantillon P, Jones R. Does continuing medical education in general practice make a difference? BMJ 1999;318:1276-9.
7. Gray JAM. Where’s the chief knowledge officer? BMJ 1998;317:832-40.
8. Magrini N, Ciardullo AV, Marata AM, et al. Come rispondere alla sfida dell’efficacia, appropriatezza e governo delle attivitŕ cliniche: l’esperienza delle aziende sanitarie modenesi. EHC (ed italiana) 1999;2:29-32.
9. Adcock PM, Sanders CL, Marshall GS. Standardizing the care of bronchiolitis. Arch Pediatr Adolesc Med 1998;152:739-44.
10. Simoes EAF. Respiratory syncytial virus infection. Lancet 1999;354:847-52.
11. Macchiaiolo M, Cascioli E, Viola L, Mastroiacovo P. Gestione del bambino con bronchiolite: un approccio basato sull’evidenza. Medico e Bambino 1999; 5:291-97.
12. Cade A, Brownlee KG, Conway SP, et al. Randomized placebo controlled trial of nebulized corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000;82:126-30.
13. Marchetti F. Trattare o non trattare? Il caso dell’otite media acuta. Medico e Bambino 1998;7:45-9.
14. Claessen JQ, Appelman CL, Tow-Otten FW, et al. A review of clinical trials regarding treatment of acute otitis media. Clin Otoralyngol 1992;17:251-7.
15. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr 1994;124:335-67.
16. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with otitis media? A meta-analysis. BMJ 1997;314:1526-9.
17. Fromm J, Culpepper L, Jacobs M, et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 1997;315:98-102.
18. Mastroiacovo P, Bonati M. Quali evidenze nel trattamento delle patologie pediatriche piů comuni? Prospettive in Pediatria 1998;28:195-206.
19. Damoiseaux R, van Balen F, Hoes A, et al. Primary care based randomized double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000;320:350-4.
20. Cates C. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. BMJ 1999;318:715-6.
21. Marolla F, Porro E. Le nuove linee guida per l’otite media acuta. Uno studio nell’ambulatorio del pediatra di famiglia. Medico e Bambino 2000, Febbraio, Pagine Elettroniche.
22. Van Buchen FAM, Peeters MF, van’t Hof MA. Acute otitis media: A new treatment strategy. BMJ 1985;290:1033-7.
23. Klein JO. Review of consensus reports on management of acute otitis media. Pediatr Infect Dis J 1999;18:1152-5.
24. Blumer JL. Fundamental basis for rational therapeutics in acute otitis media. Pediatr Infect Dis J 1999;18:1130-40.
25. Woolf SH, Grol R, Hutchinson A, et al. Potential benefits, limitations, and harms of clinical guidelines BMJ 1999;318:527-30.
26. Stross JK. Guidelines have their limits. Annals of Internal Medicine 1999;131(4):304-5.
27. Feder G, Eccles M, Grol R. Using clinical guidelines. BMJ 1998;317:465-8.
28. Rosser WW. Application of evidence from randomized controlled trials to general practice. Lancet 1999;353:661-4.
29. Wilson R, Dowling RB. Pseudomonas aeruginosa and other related species. Thorax 1998;53:213-9.
30. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after colonization with Pseudomonas aeruginosa. J Pediatr 1990;116:714-9.
31. Aebi C, Bracher R, Liechti-Gallati S, et al. The age of onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis- prognostic significance. Eur J Pediatr 1995;154 (Suppl 3):S69-S73.
32. Pamukcu A, Bush A, Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometic variables in children with cystic fibrosis. Pediatr Pulmonol 1995;19:10-5.
33. Kerem E. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers. Pediatr Pulmonol 1997 (Suppl 16):265-6.
34. Marchetti F, Candusso M, Assael BM, Faraguna D. Efficacia del trattamento antibiotico precoce nel paziente con fibrosi cistica asintomatico colonizzato dallo Pseudomonas aeruginosa: una revisione critica delle letteratura. Riv Ital Ped 2000 (submitted).
35. Rabin HR. The preservation of function: treatment of new acquisition of a pathogen. Pediatr Pulmonol 1997;23:323-4.
36. Ramsey BW, Boat TF for the Consensus Group. Outcome measures for clinical trials in cystic fibrosis. J Pediatr 1994;124:177-92.
37. Conway SP. Evidence for using nebulized antibiotics in cystic fibrosis. Arch Dis Child 1999;80:307-9.
38. Fitz Simmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122:1-9.
39. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drugs use in pediatric wards in European countries. BMJ 2000;320:79-82.
2. Liberati A (ed). La medicina delle prove di efficacia. Roma: Il Pensiero Scientifico Editore, 1997.
3. Mastroiacovo P, Bonati M (eds). Evidencebased medicine: Prospettive in Pediatria 1998; 111:147-221.
4. Haynes B, Haines A. Barriers and bridges to evidence based clinical practice. BMJ 1998;317:273-6.
5. Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998;317:465-8.
6. Cantillon P, Jones R. Does continuing medical education in general practice make a difference? BMJ 1999;318:1276-9.
7. Gray JAM. Where’s the chief knowledge officer? BMJ 1998;317:832-40.
8. Magrini N, Ciardullo AV, Marata AM, et al. Come rispondere alla sfida dell’efficacia, appropriatezza e governo delle attivitŕ cliniche: l’esperienza delle aziende sanitarie modenesi. EHC (ed italiana) 1999;2:29-32.
9. Adcock PM, Sanders CL, Marshall GS. Standardizing the care of bronchiolitis. Arch Pediatr Adolesc Med 1998;152:739-44.
10. Simoes EAF. Respiratory syncytial virus infection. Lancet 1999;354:847-52.
11. Macchiaiolo M, Cascioli E, Viola L, Mastroiacovo P. Gestione del bambino con bronchiolite: un approccio basato sull’evidenza. Medico e Bambino 1999; 5:291-97.
12. Cade A, Brownlee KG, Conway SP, et al. Randomized placebo controlled trial of nebulized corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000;82:126-30.
13. Marchetti F. Trattare o non trattare? Il caso dell’otite media acuta. Medico e Bambino 1998;7:45-9.
14. Claessen JQ, Appelman CL, Tow-Otten FW, et al. A review of clinical trials regarding treatment of acute otitis media. Clin Otoralyngol 1992;17:251-7.
15. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: meta-analysis of 5400 children from thirty-three randomized trials. J Pediatr 1994;124:335-67.
16. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with otitis media? A meta-analysis. BMJ 1997;314:1526-9.
17. Fromm J, Culpepper L, Jacobs M, et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 1997;315:98-102.
18. Mastroiacovo P, Bonati M. Quali evidenze nel trattamento delle patologie pediatriche piů comuni? Prospettive in Pediatria 1998;28:195-206.
19. Damoiseaux R, van Balen F, Hoes A, et al. Primary care based randomized double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000;320:350-4.
20. Cates C. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. BMJ 1999;318:715-6.
21. Marolla F, Porro E. Le nuove linee guida per l’otite media acuta. Uno studio nell’ambulatorio del pediatra di famiglia. Medico e Bambino 2000, Febbraio, Pagine Elettroniche.
22. Van Buchen FAM, Peeters MF, van’t Hof MA. Acute otitis media: A new treatment strategy. BMJ 1985;290:1033-7.
23. Klein JO. Review of consensus reports on management of acute otitis media. Pediatr Infect Dis J 1999;18:1152-5.
24. Blumer JL. Fundamental basis for rational therapeutics in acute otitis media. Pediatr Infect Dis J 1999;18:1130-40.
25. Woolf SH, Grol R, Hutchinson A, et al. Potential benefits, limitations, and harms of clinical guidelines BMJ 1999;318:527-30.
26. Stross JK. Guidelines have their limits. Annals of Internal Medicine 1999;131(4):304-5.
27. Feder G, Eccles M, Grol R. Using clinical guidelines. BMJ 1998;317:465-8.
28. Rosser WW. Application of evidence from randomized controlled trials to general practice. Lancet 1999;353:661-4.
29. Wilson R, Dowling RB. Pseudomonas aeruginosa and other related species. Thorax 1998;53:213-9.
30. Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after colonization with Pseudomonas aeruginosa. J Pediatr 1990;116:714-9.
31. Aebi C, Bracher R, Liechti-Gallati S, et al. The age of onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis- prognostic significance. Eur J Pediatr 1995;154 (Suppl 3):S69-S73.
32. Pamukcu A, Bush A, Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometic variables in children with cystic fibrosis. Pediatr Pulmonol 1995;19:10-5.
33. Kerem E. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers. Pediatr Pulmonol 1997 (Suppl 16):265-6.
34. Marchetti F, Candusso M, Assael BM, Faraguna D. Efficacia del trattamento antibiotico precoce nel paziente con fibrosi cistica asintomatico colonizzato dallo Pseudomonas aeruginosa: una revisione critica delle letteratura. Riv Ital Ped 2000 (submitted).
35. Rabin HR. The preservation of function: treatment of new acquisition of a pathogen. Pediatr Pulmonol 1997;23:323-4.
36. Ramsey BW, Boat TF for the Consensus Group. Outcome measures for clinical trials in cystic fibrosis. J Pediatr 1994;124:177-92.
37. Conway SP. Evidence for using nebulized antibiotics in cystic fibrosis. Arch Dis Child 1999;80:307-9.
38. Fitz Simmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122:1-9.
39. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drugs use in pediatric wards in European countries. BMJ 2000;320:79-82.